- Markets
- Healthcare
- RPGLIFE
RPGLIFE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
RPG Life Sciences Gets Tax Assessment Order With Demand Of 51.7 Million Rupees
March 21 (Reuters) - RPG Life Sciences Limited RPGL.NS:
RPG LIFE SCIENCES LIMITED - GETS TAX ASSESSMENT ORDER WITH DEMAND OF 51.7 MILLION RUPEES
Source text: ID:nBSE3F5Mj4
Further company coverage: RPGL.NS
(([email protected];;))
March 21 (Reuters) - RPG Life Sciences Limited RPGL.NS:
RPG LIFE SCIENCES LIMITED - GETS TAX ASSESSMENT ORDER WITH DEMAND OF 51.7 MILLION RUPEES
Source text: ID:nBSE3F5Mj4
Further company coverage: RPGL.NS
(([email protected];;))
India's RPG Life Sciences jumps on bigger Q3 profit
** Shares of RPG Life Sciences RPGL.NS rise as much as 13.7% to 2,370 rupees; stock last up 9.2%
** Pharmaceuticals co on Friday reported 32% Y/Y rise in Q3 net profit while rev from ops rose 12.4% Y/Y
** Stock currently above 50-day, 100-day and 200-day exponential moving averages
** Stock sees most active trading session since Oct. 7, with more than 151,000 shares change hands, 12.3x of 30-day avg
** Stock rose 63.5% in 2024, its sixth straight yearly gain
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Shares of RPG Life Sciences RPGL.NS rise as much as 13.7% to 2,370 rupees; stock last up 9.2%
** Pharmaceuticals co on Friday reported 32% Y/Y rise in Q3 net profit while rev from ops rose 12.4% Y/Y
** Stock currently above 50-day, 100-day and 200-day exponential moving averages
** Stock sees most active trading session since Oct. 7, with more than 151,000 shares change hands, 12.3x of 30-day avg
** Stock rose 63.5% in 2024, its sixth straight yearly gain
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
India's RPG Life Sciences slips after fire at Navi Mumbai plant
** RPG Life Sciences RPGL.NS falls 4% to 2,245.25 rupees
** Pharmaceuticals co reports fire incident on Jan. 2 at its manufacturing plant in Navi Mumbai; no casualties in fire
** Co yet to update on the impact on operations due to fire
** RPGL evaluating extent of damage; says has adequate insurance coverage for assets in plant
** Stock set to snap four sessions of gains
** RPGL rose 63.5% in 2024
(Reporting by Vijay Malkar)
(([email protected];))
** RPG Life Sciences RPGL.NS falls 4% to 2,245.25 rupees
** Pharmaceuticals co reports fire incident on Jan. 2 at its manufacturing plant in Navi Mumbai; no casualties in fire
** Co yet to update on the impact on operations due to fire
** RPGL evaluating extent of damage; says has adequate insurance coverage for assets in plant
** Stock set to snap four sessions of gains
** RPGL rose 63.5% in 2024
(Reporting by Vijay Malkar)
(([email protected];))
RPG Life Sciences Says Fire Incident At Plant In Navi Mumbai
Jan 3 (Reuters) - RPG Life Sciences Limited RPGL.NS:
RPG LIFE SCIENCES LIMITED - FIRE INCIDENT AT RPG LIFE SCIENCES PLANT IN NAVI MUMBAI
RPG LIFE SCIENCES LIMITED - NO CASUALTIES OR LOSS OF LIFE IN RPG LIFE SCIENCES FIRE
Source text: ID:nNSE8vGLzX
Further company coverage: RPGL.NS
(([email protected];))
Jan 3 (Reuters) - RPG Life Sciences Limited RPGL.NS:
RPG LIFE SCIENCES LIMITED - FIRE INCIDENT AT RPG LIFE SCIENCES PLANT IN NAVI MUMBAI
RPG LIFE SCIENCES LIMITED - NO CASUALTIES OR LOSS OF LIFE IN RPG LIFE SCIENCES FIRE
Source text: ID:nNSE8vGLzX
Further company coverage: RPGL.NS
(([email protected];))
India's RPG Life Sciences falls on Q2 profit slump
** Shares of RPG Life Sciences RPGL.NS fall 5.3% to 2,511.95 rupees, set for worst day in two weeks
** Pharma co reports an 84% fall in Sept-qtr profit at 42 million rupees ($497,763.03); rev from ops up 12%
** Busiest session since mid Oct.; more than 48,000 shares change hands
** Stock up ~88% so far this year, on track for sixth straight year of gains
($1 = 84.3775 Indian rupees)
(Reporting by Dimpal Gulwani in Bengaluru)
** Shares of RPG Life Sciences RPGL.NS fall 5.3% to 2,511.95 rupees, set for worst day in two weeks
** Pharma co reports an 84% fall in Sept-qtr profit at 42 million rupees ($497,763.03); rev from ops up 12%
** Busiest session since mid Oct.; more than 48,000 shares change hands
** Stock up ~88% so far this year, on track for sixth straight year of gains
($1 = 84.3775 Indian rupees)
(Reporting by Dimpal Gulwani in Bengaluru)
RPG Life Sciences Sept-Quarter Profit 42 Mln Rupees
Nov 7 (Reuters) - RPG Life Sciences Limited RPGL.NS:
SEPT-QUARTER PROFIT 42 MILLION RUPEES
SEPT-QUARTER REVENUE FROM OPERATIONS 1.72 BILLION RUPEES
Source text: ID:nBSE34vc3m
Further company coverage: RPGL.NS
(([email protected];;))
Nov 7 (Reuters) - RPG Life Sciences Limited RPGL.NS:
SEPT-QUARTER PROFIT 42 MILLION RUPEES
SEPT-QUARTER REVENUE FROM OPERATIONS 1.72 BILLION RUPEES
Source text: ID:nBSE34vc3m
Further company coverage: RPGL.NS
(([email protected];;))
India's RPG Life Sciences hits record high on Q1 profit jump
** Shares of RPG Life Sciences RPGL.NS jump 8.1% to a record high of 1,940 rupees
** The pharma co's Q1 profit rose 21% y/y, rev from ops up ~12%
** More than 280,000 shares traded, 7.1x the 30-day avg
** Stock rose 7.5% in the June-qtr, logging fifth-straight quarterly gain
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of RPG Life Sciences RPGL.NS jump 8.1% to a record high of 1,940 rupees
** The pharma co's Q1 profit rose 21% y/y, rev from ops up ~12%
** More than 280,000 shares traded, 7.1x the 30-day avg
** Stock rose 7.5% in the June-qtr, logging fifth-straight quarterly gain
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
RPG Life Sciences June-Quarter Profit 267.6 Million Rupees
July 19 (Reuters) - RPG Life Sciences Limited RPGL.NS:
JUNE-QUARTER PROFIT 267.6 MILLION RUPEES
JUNE-QUARTER REVENUE FROM OPERATIONS 1.65 BILLION RUPEES
Source text for Eikon: ID:nNSEc6nMMd
Further company coverage: RPGL.NS
(([email protected];))
July 19 (Reuters) - RPG Life Sciences Limited RPGL.NS:
JUNE-QUARTER PROFIT 267.6 MILLION RUPEES
JUNE-QUARTER REVENUE FROM OPERATIONS 1.65 BILLION RUPEES
Source text for Eikon: ID:nNSEc6nMMd
Further company coverage: RPGL.NS
(([email protected];))
RPG Life Sciences Equity Dividend Of 16 Rupees Per Share
April 30 (Reuters) - RPG Life Sciences Limited RPGL.NS:
EQUITY DIVIDEND OF 16 RUPEES PER SHARE
RPG LIFE SCIENCES MARCH-QUARTER PROFIT 132.4 MILLION RUPEES VERSUS PROFIT 103.5 MILLION RUPEES
RPG LIFE SCIENCES MARCH-QUARTER REVENUE FROM OPERATIONS 1.27 BILLION RUPEES VERSUS 1.18 BILLION RUPEES
Source text for Eikon: ID:nBSE7XFGRh
Further company coverage: RPGL.NS
(([email protected];;))
April 30 (Reuters) - RPG Life Sciences Limited RPGL.NS:
EQUITY DIVIDEND OF 16 RUPEES PER SHARE
RPG LIFE SCIENCES MARCH-QUARTER PROFIT 132.4 MILLION RUPEES VERSUS PROFIT 103.5 MILLION RUPEES
RPG LIFE SCIENCES MARCH-QUARTER REVENUE FROM OPERATIONS 1.27 BILLION RUPEES VERSUS 1.18 BILLION RUPEES
Source text for Eikon: ID:nBSE7XFGRh
Further company coverage: RPGL.NS
(([email protected];;))
Rpg Life Sciences Signs Share Subscription And Shareholders' Agreement With Sunpound Solar
March 11 (Reuters) - RPG Life Sciences Limited RPGL.NS:
SIGNED A SHARE SUBSCRIPTION AND SHAREHOLDERS' AGREEMENT WITH SUNPOUND SOLAR
AGREEMENT FOR SUBSCRIBING TO 26% STAKE OF SUNPOUND WORTH 11 MILLION RUPEES
Source text for Eikon: ID:nBSE8PCqCt
Further company coverage: RPGL.NS
(([email protected];))
March 11 (Reuters) - RPG Life Sciences Limited RPGL.NS:
SIGNED A SHARE SUBSCRIPTION AND SHAREHOLDERS' AGREEMENT WITH SUNPOUND SOLAR
AGREEMENT FOR SUBSCRIBING TO 26% STAKE OF SUNPOUND WORTH 11 MILLION RUPEES
Source text for Eikon: ID:nBSE8PCqCt
Further company coverage: RPGL.NS
(([email protected];))
India's RPG Life Sciences hits record high on Q3 profit jump
** Shares of RPG Life Sciences RPGL.NS rise as much as 4.9% to a record 1,695 rupees
** Pharma co on Thursday reported about a 39% Y/Y jump in Q3 profit on rev from ops grew ~18%
** More than 33,000 shares change hands, 1.3x their 30-day avg
** RPGL trading above its 200-day simple moving avg since June
** Stock up 2.4% for the week; on track for fifth consecutive weekly gain, if trend holds
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
** Shares of RPG Life Sciences RPGL.NS rise as much as 4.9% to a record 1,695 rupees
** Pharma co on Thursday reported about a 39% Y/Y jump in Q3 profit on rev from ops grew ~18%
** More than 33,000 shares change hands, 1.3x their 30-day avg
** RPGL trading above its 200-day simple moving avg since June
** Stock up 2.4% for the week; on track for fifth consecutive weekly gain, if trend holds
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
RPG Life Sciences Re-Appoints Yugal Sikri As MD
Feb 1 (Reuters) - RPG Life Sciences Limited RPGL.NS:
RE-APPOINTED YUGAL SIKRI AS MANAGING DIRECTOR
DEC-QTR PROFIT 264.6 MLN RUPEES VS PROFIT 191.1 MLN RUPEES
DEC-QTR CONSOL REV FROM OPS 1.54 BLN RUPEES VS 1.31 BLN RUPEES
Source text for Eikon: ID:nBSE9vTRYR
Further company coverage: RPGL.NS
(([email protected];))
Feb 1 (Reuters) - RPG Life Sciences Limited RPGL.NS:
RE-APPOINTED YUGAL SIKRI AS MANAGING DIRECTOR
DEC-QTR PROFIT 264.6 MLN RUPEES VS PROFIT 191.1 MLN RUPEES
DEC-QTR CONSOL REV FROM OPS 1.54 BLN RUPEES VS 1.31 BLN RUPEES
Source text for Eikon: ID:nBSE9vTRYR
Further company coverage: RPGL.NS
(([email protected];))
India's RPG Life Sciences hits record high on Q2 profit climb
** Shares of RPG Life Sciences RPGL.NS up as much as 3.8% to all-time high of 1,460 rupees
** Pharmaceutical co posts 29.5% YoY rise in Sept-qtr profit; rev from ops up ~14% YoY
** Over 72,000 shares change hands as of 12:34 p.m. IST, 1.8x the 30-day moving average
** Stock last up 1.3%, trimming some gains, and extending YTD gains to ~68%
(Reporting by Kashish Tandon in Bengaluru)
** Shares of RPG Life Sciences RPGL.NS up as much as 3.8% to all-time high of 1,460 rupees
** Pharmaceutical co posts 29.5% YoY rise in Sept-qtr profit; rev from ops up ~14% YoY
** Over 72,000 shares change hands as of 12:34 p.m. IST, 1.8x the 30-day moving average
** Stock last up 1.3%, trimming some gains, and extending YTD gains to ~68%
(Reporting by Kashish Tandon in Bengaluru)
India's RPG Life Sciences Sept-Quarter Profit Rises
Oct 18 (Reuters) - RPG Life Sciences Limited RPGL.NS:
INDIA'S RPG LIFE SCIENCES LIMITED SEPT-QUARTER PROFIT 258.6 MILLION RUPEES VERSUS 199.7 MILLION RUPEES
RPG LIFE SCIENCES LIMITED SEPT-QUARTER REVENUE FROM OPERATIONS 1.54 BILLION RUPEES VERSUS 1.35 BILLION RUPEES
RPG LIFE SCIENCES - EXECUTION OF POWER DELIVERY AGREEMENT WITH SUNPOUND SOLAR FOR SUPPLY OF ELECTRICITY BY POWER PRODUCER TO CO
RPG LIFE SCIENCES - AGREED TO INVEST UPTO 11 MILLION RUPEES TO SUBSCRIBE SHARES OF SUNPOUND
Source text for Eikon: ID:nBSE1DVg3t
Further company coverage: RPGL.NS
(([email protected];))
Oct 18 (Reuters) - RPG Life Sciences Limited RPGL.NS:
INDIA'S RPG LIFE SCIENCES LIMITED SEPT-QUARTER PROFIT 258.6 MILLION RUPEES VERSUS 199.7 MILLION RUPEES
RPG LIFE SCIENCES LIMITED SEPT-QUARTER REVENUE FROM OPERATIONS 1.54 BILLION RUPEES VERSUS 1.35 BILLION RUPEES
RPG LIFE SCIENCES - EXECUTION OF POWER DELIVERY AGREEMENT WITH SUNPOUND SOLAR FOR SUPPLY OF ELECTRICITY BY POWER PRODUCER TO CO
RPG LIFE SCIENCES - AGREED TO INVEST UPTO 11 MILLION RUPEES TO SUBSCRIBE SHARES OF SUNPOUND
Source text for Eikon: ID:nBSE1DVg3t
Further company coverage: RPGL.NS
(([email protected];))
India's RPG Life Sciences hits record high on qtrly profit rise
** Shares of RPG Life Sciences RPGL.NS up as much as 8.6% to hit record high of 1,128.50 rupees
** Pharmaceutical co posts ~21% YoY rise in June-qtr profit, rev from ops up ~15% YoY
** RPGL on track to rise for second straight session, if gains hold
** Over 120,000 shares change hands by 11:42 a.m. IST, 2.6x the 30-day moving avg
** As of last close, stock up ~23% so far this year
(Reporting by Kashish Tandon in Bengaluru)
** Shares of RPG Life Sciences RPGL.NS up as much as 8.6% to hit record high of 1,128.50 rupees
** Pharmaceutical co posts ~21% YoY rise in June-qtr profit, rev from ops up ~15% YoY
** RPGL on track to rise for second straight session, if gains hold
** Over 120,000 shares change hands by 11:42 a.m. IST, 2.6x the 30-day moving avg
** As of last close, stock up ~23% so far this year
(Reporting by Kashish Tandon in Bengaluru)
India's RPG Life Sciences June-Quarter Profit Rises
July 28 (Reuters) - RPG Life Sciences Limited RPGL.NS:
JUNE-QUARTER PROFIT 221 MILLION RUPEES VERSUS PROFIT 182.1 MILLION RUPEES
JUNE-QUARTER REVENUE FROM OPERATIONS 1.48 BILLION RUPEES VERSUS 1.29 BILLION RUPEES
Source text for Eikon: ID:nBSE2gktTV
Further company coverage: RPGL.NS
(([email protected];))
July 28 (Reuters) - RPG Life Sciences Limited RPGL.NS:
JUNE-QUARTER PROFIT 221 MILLION RUPEES VERSUS PROFIT 182.1 MILLION RUPEES
JUNE-QUARTER REVENUE FROM OPERATIONS 1.48 BILLION RUPEES VERSUS 1.29 BILLION RUPEES
Source text for Eikon: ID:nBSE2gktTV
Further company coverage: RPGL.NS
(([email protected];))
India's RPG Life Sciences Mar-Quarter Profit Rises
April 28 (Reuters) - RPG Life Sciences Limited RPGL.NS:
MAR-QUARTER PROFIT 103.5 MILLION RUPEES VERSUS PROFIT 75.2 MILLION RUPEES
MAR-QUARTER REVENUE FROM OPERATIONS 1.18 BILLION RUPEES VERSUS 1.04 BILLION RUPEES
DIVIDEND OF 12 RUPEES PER SHARE
Further company coverage: RPGL.NS
(([email protected];))
April 28 (Reuters) - RPG Life Sciences Limited RPGL.NS:
MAR-QUARTER PROFIT 103.5 MILLION RUPEES VERSUS PROFIT 75.2 MILLION RUPEES
MAR-QUARTER REVENUE FROM OPERATIONS 1.18 BILLION RUPEES VERSUS 1.04 BILLION RUPEES
DIVIDEND OF 12 RUPEES PER SHARE
Further company coverage: RPGL.NS
(([email protected];))
Upcoming Events:
Quarterly Results
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does RPG Life Sciences do?
RPG Life Sciences is a research-based pharmaceutical company under RPG Enterprises. It operates in Branded Formulations, Global Generics, and Synthetic APIs markets, producing a wide range of quality and affordable medicines.
Who are the competitors of RPG Life Sciences?
RPG Life Sciences major competitors are Gufic Biosciences, Sequent Scientific, Guj. Themis Biosyn, Advanced Enzyme, Aarti Drugs, Dishman Carbogen Amc, Orchid Pharma. Market Cap of RPG Life Sciences is ₹3,736 Crs. While the median market cap of its peers are ₹3,370 Crs.
Is RPG Life Sciences financially stable compared to its competitors?
RPG Life Sciences seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does RPG Life Sciences pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. RPG Life Sciences latest dividend payout ratio is 30.18% and 3yr average dividend payout ratio is 30.12%
How has RPG Life Sciences allocated its funds?
Companies resources are allocated to majorly unproductive assets like Capital Work in Progress
How strong is RPG Life Sciences balance sheet?
Balance sheet of RPG Life Sciences is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of RPG Life Sciences improving?
The profit is oscillating. The profit of RPG Life Sciences is ₹79.13 Crs for TTM, ₹87.66 Crs for Mar 2024 and ₹67.64 Crs for Mar 2023.
Is the debt of RPG Life Sciences increasing or decreasing?
Yes, The debt of RPG Life Sciences is increasing. Latest debt of RPG Life Sciences is -₹34.03 Crs as of Sep-24. This is greater than Mar-24 when it was -₹72.92 Crs.
Is RPG Life Sciences stock expensive?
Yes, RPG Life Sciences is expensive. Latest PE of RPG Life Sciences is 47.21, while 3 year average PE is 26.41. Also latest EV/EBITDA of RPG Life Sciences is 23.9 while 3yr average is 15.49.
Has the share price of RPG Life Sciences grown faster than its competition?
RPG Life Sciences has given better returns compared to its competitors. RPG Life Sciences has grown at ~27.26% over the last 7yrs while peers have grown at a median rate of 13.84%
Is the promoter bullish about RPG Life Sciences?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in RPG Life Sciences is 72.95% and last quarter promoter holding is 72.95%.
Are mutual funds buying/selling RPG Life Sciences?
The mutual fund holding of RPG Life Sciences is increasing. The current mutual fund holding in RPG Life Sciences is 3.53% while previous quarter holding is 3.47%.